| Nombre del producto |
levidipine |
| Sinónimos |
(±)-Hydroxymethyl Methyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate Butyrate (Ester); (Butyryloxy)methyl Methyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate; 166432-28-6; Clevidipine [INN]; Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate; (butanoyloxy)methyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; (butanoyloxy)methyl methyl (4R)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; Clevidipine |
| Fórmula molecular |
C21H23Cl2NO6 |
| Peso Molecular |
456.3164 |
| InChI |
InChI=1/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3/t18-/m1/s1 |
| Número de registro CAS |
166432-28-6 |
| Estructura Molecular |
|
| Densidad |
1.289g/cm3 |
| Punto de ebullición |
539.7°C at 760 mmHg |
| Índice de refracción |
1.542 |
| Punto de inflamación |
280.2°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
